Tralau-Stewart, C. J., Wyatt, C. A., Kleyn, D. E. & Ayad, A. Drug discovery: new models for industry-academic partnerships. Drug Discov. Today 14, 95–101 (2009).
Sharma, S. et al. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer. Cell Chem. Biol. 30, 1191–1210 (2023).
Prinz, F., Schlange, T. & Asadullah, K. Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712 (2011).
Bashore, F. M. et al. Fused tetrahydroquinolines are interfering with your assay. J. Med. Chem. 66, 14434–14446 (2023).
Baragaña, B. et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522, 315–320 (2015).
留言 (0)